Related Experiment Video
Updated: Dec 13, 2025

Author Spotlight: Development of a Minimally Invasive Large-Animal Model for Reliable and Reproducible Cardiovascular Research
Published on: October 20, 2023
Patient Management in Aortic Stenosis: Towards Precision Medicine Through Protein Analysis, Imaging and Diagnostic
Laura Mourino-Alvarez1, Tatiana Martin-Rojas1, Cecilia Corros-Vicente2,3
1Department of Vascular Physiopathology, Hospital Nacional de Paraplejicos (HNP), SESCAM, 45071 Toledo, Spain.
Insights
Aortic stenosis, a common heart valve disease, lacks early symptoms. This review explores promising protein markers and precision medicine for earlier detection and treatment of this growing health challenge.
Area of Science:
- Cardiology
- Biomarkers
- Translational Medicine
Background:
- Aortic stenosis is the most common valvular heart disease in developed nations.
- It is characterized by progressive leaflet calcification, often presenting with nonspecific symptoms late in its course.
- The increasing elderly population and patient comorbidities present significant management challenges.
Purpose of the Study:
- To review key findings and translational studies on protein markers for aortic stenosis.
- To discuss the potential role of precision medicine in managing aortic stenosis.
- To identify indicators for early diagnosis, prognosis, and therapy.
Main Methods:
- Comprehensive literature review of observational and translational studies.
- Analysis of research on protein markers associated with aortic stenosis.
- Discussion of precision medicine applications in the context of aortic stenosis.
Main Results:
- Several protein markers show promise for clinical implementation in diagnosing and managing aortic stenosis.
- Early detection of aortic stenosis remains a significant unmet need.
- Precision medicine approaches may offer tailored therapeutic strategies.
Conclusions:
- Identifying reliable diagnostic, prognostic, and therapeutic indicators is crucial for early aortic stenosis detection.
- Protein markers and precision medicine represent key areas for future clinical advancements in aortic stenosis care.
Abstract:
Aortic stenosis is the most frequent valvular disease in developed countries. It progresses from mild fibrocalcific leaflet changes to a more severe leaflet calcification at the end stages of the disease. Unfortunately, symptoms of aortic stenosis are unspecific and only appear when it is too late, complicating patients' management. The global impact of aortic stenosis is increasing due to the growing elderly population. The disease supposes a great challenge because of the multiple comorbidities of these patients. Nowadays, the only effective treatment is valve replacement, which has a high cost in both social and economic terms. For that reason, it is crucial to find potential diagnostic, prognostic and therapeutic indicators that could help us to detect this disease in its earliest stages. In this article, we comprehensively review several key observations and translational studies related to protein markers that are promising for being implemented in the clinical field as well as a discussion about the role of precision medicine in aortic stenosis.
Related Concept Videos
Aortic Regurgitation III: Medical Management
Atherosclerosis III: Management
Mitral Stenosis III: Medical Management
Aortic Regurgitation IV: Nursing Management
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
Atherosclerosis IV: Nursing Management

